2019 annual financial data
Celldex Therapeutics 2019 Operating margin
Direct answer
Operating margin was -1,540.19%.
Operating income was -55,031,000 USD and net income was -50,878,000 USD.
Operating cash flow was -46,415,000 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,573,000 USD
- Operating income
- -55,031,000 USD
- Net income
- -50,878,000 USD
- Operating cash flow
- -46,415,000 USD